Literature DB >> 3689040

Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance.

D C Kaseje1, E K Sempebwa, H C Spencer.   

Abstract

Chloroquine prophylaxis for malaria was available free of charge to pregnant women in Saradidi, Kenya. The drug was supplied by village health helpers (VHH's). However, only 29.1% of 357 pregnant women seen in antenatal clinics from 1983 to 1984 were on chemoprophylaxis. One hundred and seven pregnant women not using antimalarial chemoprophylaxis from 22 villages were interviewed in June 1984 to determine the reasons. Age (mean 26.9 years), parity (mean 4.5 children), occupation (96.3% subsistence farmers and housewives) and education (median five to seven years) of the 107 respondents were similar to other women in the area. Previous pregnancies had occurred in 92 women; for 15 this was the first pregnancy. The last pregnancy had resulted in a live birth for 81 (88.0%), a stillbirth for nine (9.8%) and a miscarriage for two (2.2%); 21 (22.8%) of the 92 had experienced a miscarriage or stillbirth at some time (15 once, five twice and one woman four times). Malaria was the most frequent mentioned (28.6% of 21 women) cause of the last stillbirth or abortion. The major reason for not taking chemoprophylaxis was lack of awareness that the service was available (53.3% of 107 women). Other reasons were fear of chloroquine-induced itching (10.3%), the VHH had no drug (8.4%), the VHH had not advised her to take drug (8.4%), the woman was 'not sick' (7.5%), the woman was 'lazy' (6.5%), she had not been advised by clinic so was afraid to mix medicines (3.7%) and chloroquine was 'bad for pregnancy' (1.9%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689040     DOI: 10.1080/00034983.1987.11812191

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  3 in total

Review 1.  A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas.

Authors:  P Garner; B Brabin
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

2.  A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.

Authors:  Sabine Gies; Sheick Oumar Coulibaly; Florence Tiemegna Ouattara; Clotilde Ky; Bernard John Brabin; Umberto D'Alessandro
Journal:  Malar J       Date:  2008-09-18       Impact factor: 2.979

Review 3.  Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.

Authors:  R Matthew Chico; Rudiger Pittrof; Brian Greenwood; Daniel Chandramohan
Journal:  Malar J       Date:  2008-12-16       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.